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The Nrf2/anti-oxidant response element (ARE) pathway plays an important role in regulating cellular
anti-oxidants, including haem oxygenase-1 (HO-1). Various kinases have been implicated in the path-
ways leading to Nrf2 activation. Here, we investigated the effect of epigallocatechin (EGC) on ARE-med-
iated gene expression in human monocytic cells. EGC time and dose dependently increased HO-1 mRNA
and protein expression but had minimal effect on expression of other ARE-regulated genes, including
NAD(P)H:quinone oxidoreductase 1, glutathione cysteine ligase and ferritin. siRNA knock down of Nrf2
signiﬁcantly inhibited EGC-induced HO-1 expression. Furthermore, inhibition of PKC by Ro-31-8220 dose
dependently decreased EGC-induced HO-1 mRNA expression, whereas MAP kinase and phosphatidylin-
ositol-3-kinase pathway inhibitors had no signiﬁcant effect. EGC stimulated phosphorylation of PKCab
and d in THP-1 cells. PKCd inhibition signiﬁcantly decreased EGC-induced HO-1 mRNA expression,
whereas PKCa- and b-speciﬁc inhibitors had no signiﬁcant effect. These results demonstrate for the ﬁrst
time that EGC-induced HO-1 expression occurs via PKCd and Nrf2.
 2008 Elsevier Inc. Open access under CC BY license.Catechins, a family of plant polyphenols, exert anti-oxidant,
anti-inﬂammatory and anti-proliferative effects in vitro and
in vivo [1,2]. This may be in part due to their activation of Phase
II enzymes and cellular anti-oxidants, including NAD(P)H:quinone
oxidoreductase 1 (NQO1), catalase and enzymes involved in gluta-
thione synthesis [3–5]. These and other cytoprotective molecules,
including haem oxygenase-1 (HO-1, the rate-limiting enzyme in
haem catabolism) and the iron-binding protein ferritin, contain
anti-oxidant response elements (ARE) in the regulatory regions of
their genes. The transcription factor NF-E2-related factor 2 (Nrf2)
binds to this regulatory element and plays a key role in ARE-driven
gene transcription [6]. Nrf2 knockout mice are deﬁcient in cellular
anti-oxidants and are susceptible to inﬂammation [7,8], demon-
strating the importance of this pathway in cellular defence. Several
kinase pathways have been implicated in activation of Nrf2 includ-
ing the ERK and p38 MAP kinase pathways, phosphatidyl inositol 3
kinase and protein kinase C (PKC) [9–14].
Green tea is a rich source of catechins, comprising over 30% of
its dry weight [15]. Green tea extract activates ARE-mediated re-
porter activity [16]. EGCG is the most abundant catechin in green
tea and studies to date have focused on this compound. EGCG stim-ical Sciences and Pharmacy,
4 7TJ, UK. Fax: +44 (0)1603
nell).
 license.ulates expression of many Nrf2-dependent genes in liver and intes-
tine in mice and activates HO-1 expression in B lymphoblasts,
epithelial and endothelial cells [13,14,17,18]. Epigallocatechin
(EGC) is also a major catechin in green tea [19]. Although EGCG
and EGC are structurally similar except for the addition of a 3-gal-
late group in EGCG, their biological effects differ extensively [3,20–
26]. EGC is also more bioavailable than EGCG and other catechins
and oral administration of EGC, but not EGCG, results in a signiﬁ-
cant increase in plasma anti-oxidant activity [27].
Monocytes play an essential role in the host response to oxida-
tive stress and inﬂammation. In the present study, the effects of
EGC on ARE-mediated gene expression were examined in THP-1
cells, a human monocytic cell line that we have previously used
to examine ARE-mediated gene expression [9–11]. In addition,
the role of Nrf2 and the various potential kinase pathways leading
to Nrf2 activation were investigated.Materials and methods
Materials. LY333531 was purchased from Alexis Biotechnologies
(Nottingham, UK). SB203580, Ro-31-8220, rottlerin, LY294002,
Go6976 and PD98059 were obtained from Calbiochem (Notting-
ham, UK). ()Epigallocatechin and all other chemicals were pur-
chased from Sigma (Poole, UK).
Cell culture. THP-1, a human monocytic leukaemia cell line [28],
was purchased from ECACC (Porton Down, UK) and cultured in
Fig. 1. EGC increases HO-1 expression. (A) THP-1 cells were treated with 0–100 lM
EGC for 4, 8 or 24 h. RNA was extracted, reverse transcribed and real-time PCR
performed for HO-1 mRNA expression. Mean ± SD, three independent experiments.
Student’s two-tailed t test, *p < 0.05, **p < 0.01. (B) THP-1 cells were treated with
100 lM EGC for indicated times, whole cell extracts prepared and Western blotting
performed. Representative of three independent experiments.
Fig. 2. Nrf2 regulates EGC-induced HO-1 mRNA expression. THP-1 cells were
transfected with control or Nrf2-targeted siRNA in serum-free media for 4 h
followed by addition of 10% FCS for 44 h. Following this, cells were stimulated with
EGC for 4 h before RNA extraction, reverse transcription and real-time PCR analysis
for Nrf2 or HO-1 mRNA expression. Mean ± SD three independent experiments.
Student’s two-tailed t test, *p < 0.05.
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2 mM L-glutamine (Biowhittaker, Wokingham, UK) and 2-mercap-
toethanol. Cells were maintained in a humidiﬁed atmosphere at
37 C and 5% CO2.
Western immunoblotting. Cells (1  106) were unstimulated or
stimulated with EGC and whole cell lysates prepared, proteins sep-
arated and immunoblotting carried out as previously described
[11]. Antibodies were purchased from the following: mouse anti-
human HO-1 antibody (Stressgen Biotechnologies Corporation,
Victoria, Canada); rabbit anti-human phosphorylated PKCab and
PKCd antibodies (Cell Signalling Technology, Beverley, USA);
mouse anti-human endogenous PKCd antibody (BD Biosciences,
CA, USA); goat anti-mouse and goat anti-rabbit secondary antibod-
ies (Santa Cruz Biotechnology, Santa Cruz, USA); mouse anti-hu-
man b-actin antibody (Sigma).
Real-time PCR. Cells (5  105) were unstimulated or stimulated
with EGC for various times at 37 C. In some experiments, cells
were pre-treated with kinase inhibitors for 30 min prior to EGC
stimulation. RNA extraction, reverse transcription, and real-time
PCR were carried out as previously described [10]. Relative quanti-
tative mRNA expression of HO-1, NQO1, GCLM or ferritin was nor-
malized to 18s ribosomal unit mRNA expression.
Nrf2 siRNA transfection. Nrf2 siRNA sense sequences 50-GAGUAU
GAGCUGGAAAAACtt-30 (siNrf2 A) [29], 50-CCUUAUAUCUCGAAG
UUUUtt-30 (siNrf2 B), their complementary antisense sequences
and negative controls were obtained from Ambion as puriﬁed an-
nealed duplexes. THP-1 cells (5  104/well) were transfected in
serum-free media with control siRNA or Nrf2-targeted siRNA
(30 nM ﬁnal concentration), using Oligofectamine transfection re-
agent according to the manufacturer’s instructions (Invitrogen).
Transfected cells were incubated for 48 h, with addition of 10%
FCS at 4 h. Following this, cells were stimulated with EGC for 4 h
before RNA extraction and real-time PCR analysis.
PKCd antisense oligodeoxyribonucleotide (ODN) transfection. THP-
1 cells (5  104) were transfected in serum-free media with sense
or antisense ODN to PKCd, using Oligofectamine transfection re-
agent (Invitrogen), as previously described [10]. Following trans-
fection, cells were unstimulated or stimulated with EGC for 4 h,
total RNA extracted and real-time PCR performed.
Statistical analyses. Where indicated, statistical analyses were
performed using paired Student’s t test. Results are means ± SD
of three independent experiments. Results with p < 0.05 were con-
sidered statistically signiﬁcant.
Results
EGC increases HO-1 expression in THP-1 cells
EGC increased HO-1 mRNA expression in THP-1 cells, peaking
at 4 h (p < 0.01), remaining elevated at 8 h (p < 0.01) and return-
ing to baseline by 24 h (Fig. 1A). This correlated with an eleva-
tion in HO-1 protein expression by 4 h, which further
increased by 8 h and decreased, but was still evident, at 24 h
(Fig. 1B). EGC also time and dose dependently increased GCLM
mRNA expression in THP-1 cells with maximal induction at
4 h. However, the induction was much weaker than that seen
with HO-1 (GCLM at 4 h, 50 lM EGC, 2.5 ± 0.5, p < 0.01;
100 lM EGC, 3.0 ± 1.30, p < 0.01, mean fold increase above con-
trol ± SD, n = 7). EGC (12.5–100 lM) had no signiﬁcant effect on
either NQO1 or ferritin gene expression up to 24 h (data not
shown). To ensure that EGC-induced HO-1 expression was not
the result of toxicity, THP-1 cells pre-incubated with EGC for
24 h were analysed by MTT assay. At concentrations up to
125 lM THP-1 cells remained 96% (±2.3) viable compared to
control cells, suggesting that the EGC concentrations used in this
study did not exert cytotoxic effects.Role of Nrf2 in EGC-induced HO-1 expression
Nrf2 plays a key role in HO-1 regulation. The role of Nrf2 in
EGC-induced HO-1 expression was conﬁrmed by use of siRNA.
THP-1 cells were transiently transfected with control or two differ-
ent Nrf2 siRNAs and Nrf2 mRNA expression measured by real-time
PCR. Fig. 2A demonstrates that both Nrf2 siRNAs signiﬁcantly
inhibited Nrf2 mRNA expression to a similar extent when com-
pared with the negative control (black bars, p = 0.004, p = 0.0002,
respectively). These siRNAs also inhibited Nrf2 protein expression
(data not shown). In addition, they signiﬁcantly inhibited EGC-in-
duced HO-1 mRNA expression (grey bars, A, 60.7 ± 8.9, p = 0.01;
B, 66.1 ± 2.6, p = 0.0007; mean ± SD% inhibition, n = 3), conﬁrming
that Nrf2 plays a key role in this pathway in THP-1 cells.
Investigation of kinase pathways regulating EGC-induced HO-1
expression
THP-1 cells were pre-treated with LY294002 (a PI3K inhibitor),
SB203580 (a p38 MAPK inhibitor), PD98059 (an ERK MAPK path-
way inhibitor) or Ro-31-8220 (a pan-PKC inhibitor) prior to stimu-
lation with EGC. LY294002, SB203580 and PD98059 had no
Fig. 3. EGC-induced HO-1 mRNA expression is PKC-dependent. THP-1 cells were
pre-treated with (A) 25 lM LY294002 (LY), 25 lM PD98059 (PD), 10 lM SB203580
(SB) or 5 lM Ro-31-8220 (Ro) or (B) varying concentrations of Ro-31-8220 for
30 min prior to stimulation with 100 lM EGC for 4 h. Total RNA was extracted,
reverse transcribed and HO-1 mRNA expression detected by real-time PCR.
Mean ± SD three independent experiments. Student’s two-tailed t test, *p < 0.05.
(C) THP-1 cells were treated with 100 lM EGC for indicated times, whole cell
extracts prepared and Western blotting performed. Representative of three
independent experiments.
Fig. 4. EGC-induced HO-1 expression is PKCd-dependent. (A) THP-1 cells were
treated with 100 lM EGC for indicated times, whole cell extracts prepared and
Western blotting performed. Representative of three independent experiments. (B)
Cells were pre-treated with 10 lM Go6976, 0.02 lM LY333531 or 15 lM Rottlerin
for 30 min prior to stimulation with 100 lM EGC for 4 h. Total RNA was extracted,
reverse transcribed and HO-1 mRNA expression detected by real-time PCR.
Mean ± SD three independent experiments. Student’s two-tailed t test, *p < 0.05.
(C) THP-1 cells were transfected with sense (SO) or antisense (ASO) ODN to PKCd in
serum-free media for 4 h followed by addition of 10% FCS for 44 h. Following
transfection, cells were unstimulated or stimulated with indicated concentrations
of EGC for 4 h, total RNA extracted, reverse transcribed and HO-1 mRNA expression
detected by real-time PCR. Mean ± SD three independent experiments. Student’s
two-tailed t test, *p < 0.05.
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ever, pre-treatment with Ro-31-8220 abolished EGC-induced
HO-1 mRNA expression (p < 0.05) (Fig. 3A), suggesting that this re-
sponse is regulated by PKC. The effect of Ro-31-8220 upon EGC-in-
duced HO-1 mRNA expression was concentration-dependent,
conﬁrming the speciﬁcity of this effect (Fig. 3B). Ro-31-8220
(5 lM) also completely abolished EGC-induced GCLM mRNA
expression in these cells (data not shown). Furthermore, EGC
induced phosphorylation of PKC within 5 min, peaked at 20 min
(Fig. 3C) and remained phosphorylated at 4 and 8 h (data not
shown). These results suggest that PKC plays a key role in EGC-
induced HO-1 (and GCLM) expression in THP-1 cells.
EGC-induced HO-1 expression is regulated by PKCd
The PKC family of proteins comprises at least 10 serine/threo-
nine kinases [30]. We have shown that LPS and curcumin-induced
HO-1 expression in THP-1 cells are mediated via a classical PKC
isoform and PKCd, respectively [10,11]. The potential role of these
PKC isoforms in regulating EGC-induced HO-1 expression in THP-1
cells was examined. EGC induced phosphorylation of classical
PKCs(ab) and PKCd by 5 min, which was sustained at 30 min (Fig.
4A). This was not the result of a change in expression of unphos-
phorylated PKC isoforms. Cells were also pre-treated with
LY333531 (a PKC b1/b2 inhibitor), Go6976 (a PKCa/b1 inhibitor)or rottlerin (which inhibits PKCd and h at the concentrations used)
prior to stimulation with EGC and real-time PCR performed.
LY333531 and Go6976 exerted no signiﬁcant effect on EGC-in-
duced HO-1 mRNA expression, suggesting that classical PKC iso-
forms are not important for this pathway. However, 15 lM
rottlerin signiﬁcantly inhibited EGC-induced HO-1 mRNA expres-
sion (p < 0.05) (Fig. 4B), suggesting that, similarly to curcumin,
PKCd may be important in HO-1 induction by EGC. Rottlerin, but
not Go6976 or LY333531, also inhibited EGC-induced GCLM mRNA
expression in THP-1 cells by 61% (data not shown). As rottlerin
may also inhibit PKCh and other kinase pathways, PKCd antisense
ODN were employed to conﬁrm speciﬁcity. PKCd antisense ODN
inhibited PKCd protein expression in THP-1 cells [10]. Transfection
of PKCd sense ODN did not affect EGC-induced HO-1 mRNA expres-
sion (Fig. 4C). However, transfection of antisense ODN prior to EGC
stimulation resulted in a 78% reduction (p < 0.005) in EGC-induced
HO-1 mRNA expression, conﬁrming a role for PKCd in the regula-
tion of EGC-induced HO-1 expression.
Discussion
Green tea extract activates ARE-dependent gene expression and
studies to date have focused on EGCG. In the present study, EGC, a
more bioavailable catechin found in green tea, induced HO-1
R.M. Ogborne et al. / Biochemical and Biophysical Research Communications 373 (2008) 584–588 587expression and GCLM expression in human monocytic THP-1 cells.
Furthermore, EGC-induced HO-1 expression was regulated by Nrf2
and PKCd.
We have previously reported the activation of Nrf2/ARE-medi-
ated gene expression by dietary anti-oxidants in THP-1 cells. Alpha
lipoic acid activates Nrf2-mediated HO-1 expression [9] and curcu-
min activates expression of Nrf2-regulated HO-1, NQO1,
glutathione cysteine ligase and ferritin [10]. However, other die-
tary anti-oxidants including ascorbic acid, alpha tocopherol, gam-
ma tocopherol and resveratrol do not activate these genes in
THP-1 cells (unpublished). In the present study, EGC activated
HO-1 and GCLM, but not NQO1 or ferritin expression in THP-1
cells. EGCG minimally increases HO-1 mRNA expression in THP-1
cells (unpublished). EGCG activates HO-1 mRNA and protein
expression in epithelial and endothelial cells at similar concentra-
tions used in our study [14,18]. However, in contrast to our results,
100 lM EGC had no effect on HO-1 protein expression in endothe-
lial cells, which may be due to differences in cell type. Nrf2 regu-
lates EGCG-induced HO-1 in B lymphoblasts and epithelial cells
[13,18]. Here, EGC also activated Nrf2 in THP-1 cells, and Nrf2
silencing signiﬁcantly suppressed EGC-induced HO-1 expression,
suggesting a key role for this transcription factor in this pathway.
However, EGC did not activate ARE-driven reporter activity in
HepG2 cells transfected with an ARE reporter [3].
Small differences in catechin structure result in wide-ranging
biological effects. The presence of a 3-gallate group in EGCG and
epicatechin gallate (ECG) results in pharmacokinetic differences.
EGC is more bioavailable than either EGCG or ECG and oral admin-
istration of EGC results in a higher plasma anti-oxidant activity
than that seen with gallated catechins [27], suggesting that it
may be more important in vivo. In addition, cellular effects differ
between gallated and non-gallated catechins. EGCG and ECG, but
not EGC, bind to oestrogen receptors in MCF7 cells [21]. However,
in the same study, EGCG, but not EGC or the gallated ECG, activated
oestrogen receptor-mediated gene expression. Catechins also exhi-
bit varying cytotoxic effects in different cells [3,22]. In addition,
EGCG, but not EGC, (i) binds to the metastasis-associated laminin
receptor in tumour cells, (ii) disrupts liposome membrane
structure, (iii) inhibits CYP450 isoforms, (iv) inhibits proteasome
activity and (v) suppresses Type I collagen and matrix metallopro-
teinase 1 production [20,23–26].
Several kinase pathways may regulate EGC-induced HO-1 and
GCLM expression in THP-1 cells. ALA and curcumin induce HO-1
expression through p38 MAPK in THP-1 cells [9,10]. EGCG also
activates Nrf2 expression in B lymphoblasts via p38 MAP kinase
[13]. Here, the p38 MAPK inhibitor SB203580 did not signiﬁcantly
inhibit EGC-induced HO-1 mRNA expression, suggesting this path-
way is not involved. EGC activates ERK MAP kinases in Ehrlich asci-
tes tumour cells and HepG2 cells [3,22] and EGCG-induced HO-1
expression in epithelial and endothelial cells is regulated by ERK
MAP kinase and PI3K [14,18]. However, we found that inhibitors
of these pathways had no effect on EGC-induced HO-1 expression
in THP-1 cells.
The present study implicates a role for PKCd in Nrf2-regulated
EGC-induced HO-1 expression. PKC regulates ARE-mediated gene
expression in various cell types [10–12]. PKC phosphorylates
Nrf2 on Ser40, enabling dissociation from its inhibitor Keap 1
[31]. EGCG activates PKC in neuronal, astroglioma and phaeochro-
macytoma cells [32–34]. However, PKC inhibitors did not affect
EGCG-induced HO-1 expression in endothelial cells [14]. We have
previously shown that a classical PKC regulates LPS-induced HO-1
expression in monocytes [11]. However, inhibitors of classical PKC
had no signiﬁcant effect in this study. However, PKCd inhibitors
suppressed EGC-induced HO-1 expression. In addition, Ro-31-
8220 and rottlerin, but not Go6976 or LY333531, signiﬁcantly
inhibited EGC-induced GCLM expression, suggesting that PKCd alsoregulates EGC-induced GCLM mRNA expression in THP-1 cells.
Curcumin-induced HO-1 and GCLM expression are mediated via
PKCdd in human monocytes and THP-1 cells, suggesting a common
pathway of activation for these polyphenols. However, p38 also
regulates curcumin-induced HO-1 expression in THP-1 cells [10],
suggesting some divergence in the two pathways. Based on our
studies and other recent reports [10,12,35], PKCd is emerging as
an important member of the signalling pathways leading to Nrf2/
ARE-mediated gene expression and its exact role warrants further
investigation.
GCLM is the regulatory unit of the rate-limiting enzyme of glu-
tathione synthesis and GCLM induction leads to an increase in glu-
tathione in cells [36]. In the present study, EGC weakly increased
GCLM mRNA expression in THP-1 cells. In contrast, EGC decreased
glutathione concentrations in Ehrlich ascites tumour cells but this
correlated with cell viability [22]. EGC was not cytotoxic at the
concentrations used here, suggesting this may be a reason for the
differences between the two studies. Interestingly, although
NQO1 and ferritin are also regulated by the ARE and green tea ex-
tract activates NQO1 in vitro and in vivo [3,4], EGC did not activate
these genes in THP-1 cells, suggesting that an alternative catechin
may be responsible for the effect of green tea extracts on NQO1
expression or that this effect is cell type-speciﬁc.
In conclusion, EGC, in addition to EGCG, contributes to the acti-
vation of cellular anti-oxidants by catechins, including HO-1 and
this, in turn, may partially be responsible for the beneﬁcial effects
of green tea extracts in vitro and in vivo. HO-1 plays a protective
role in models of vascular diseases [37,38], suggesting that activa-
tion of HO-1 by EGC warrants further investigation. In addition,
PKCd regulates EGC-induced HO-1 expression, conﬁrming that this
kinase is emerging as an important member of the signalling path-
ways leading to HO-1.
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